Gregg Ashby is the Vice President of Finance of Genevant Sciences Corporation having joined the company in December 2020. Previously, he was at Arbutus Biopharma for 15 years where he progressed to the Senior Director of Finance role and led the financial aspects of collaborations, tax, reporting, budgeting, HR, internal controls and operations. He started his career with Ernst & Young and has also worked in private equity and tech. Gregg is a CPA and has a B.Sc. in Managerial and Administrative Studies from Aston University, UK.